Prior to 1988, endometrial cancer was clinically staged but there was the considerable discerpancy between clinical and actual stage. FIGO surgical staging classification of endometrial cancer(1988) provides the advanatage of recognizing the true
disease distribution and extension, and more rational treatment can be accomplished.
This retrospective study was based on a clinical review of 73 patients with endometrial carcinoma from 1982 through 1991 who underwent primary surgical evaluation. All cases were restaged using the newly adopted FIGO surgical staging.
The distribution of FIGO clinical staging was as follows:b5 patients(89.1%) were with stage I, 5(6.9%) with stage II, 2(2.7%) with stage III and 1(1.3%) with stageⅣ. Surgical restaging according new FIGO classification revealed 56(76.7%)
patients
with
stage I, 1(1.4%) with stageⅡ, 14(19.2%) with stage Ⅲ and 2(2.7%) with stage Ⅳ. Surgery upstaged 12.3% of clinical stage I patients. In clinical stageⅡ patients, 80.0% was downstaged. There was no stage changing in clinical stage Ⅲ and
Ⅳpatients.
The acturial survival rates for surgical stages Ia, Ib, Ic, and Ⅲ were 80.0%, 77.2%, 6.4%, and 35.0% respectively. By using FIGO surgical staging, the initial extent of endometrial cancer can be more accurately evaluated and we may predict
prognosis
and survival relatively well.
|